n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone has been researched along with nicotine in 1 studies
Studies (n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone) | Trials (n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone) | Recent Studies (post-2010) (n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone) | Studies (nicotine) | Trials (nicotine) | Recent Studies (post-2010) (nicotine) |
---|---|---|---|---|---|
15 | 0 | 0 | 28,519 | 2,280 | 9,302 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dóda, M; Gellén, B; György, L; Sterk, L | 1 |
1 other study(ies) available for n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone and nicotine
Article | Year |
---|---|
Pharmacology of 1-(2-oxo-1-pyrrolidino)-4-(2-chloroethyl-methylamino)but-2-yne-HCl (DSO-16), I. Its central cholinomimetic and cholinolytic effects on mice.
Topics: Alkynes; Analgesia; Animals; Drug Antagonism; Drug Synergism; Female; Hexobarbital; Male; Methylamines; Mice; Myasthenia Gravis; Mydriatics; Nicotine; Nicotinic Acids; Parasympatholytics; Parasympathomimetics; Pentobarbital; Physostigmine; Pyrrolidinones; Tremor | 1971 |